Dr. Miron Derchansky gives us an insightful peek into the technology trends being talked about in the boardrooms of healthcare organizations around the world. He also provides practical guidance on how organizations and individuals can harness innovation for their business. Dr. Derchansky is the founder and president of Blackletter group. Blackletter helps life sciences executives identify and operationalize innovation at the intersection of digital and pharma.
More About Blackletter
At Blackletter, we help life sciences executives identify and operationalize innovation at the intersection of digital and pharma. This involves a deep assessment of nascent opportunity spaces from scientific and commercial perspective, scouting for technologies in highly innovative ecosystems like Singapore and Israel and setting up small scale experiments and pilots as a tangible first step in executing innovation within a larger corporate structure.
Connect with Dr. Miron Derchansky on LinkedIn (www.linkedin.com/in/mironderchansky) or via the Blackletter website at blackletter.group.